Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonanemic Iron Deficiency in Cardiac Surgery: A Retrospective Observational Study.

Journal of cardiothoracic and vascular anesthesia·2024
Same author

Atezolizumab-induced hemolytic anemia - A case report.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2020
Same author

Severe sunitinib-induced myelosuppression in a patient with a CYP 3A4 polymorphism.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2017
Same author

Prevalence and progression of refractive errors among medical students.

Indian journal of physiology and pharmacology·2013
Same author

Outcomes of computerized physician order entry in an electronic health record after implementation in an outpatient oncology setting.

Journal of oncology practice·2011

Related Experiment Video

Updated: Nov 12, 2025

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:31

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

143

Pemigatinib-induced nail changes - A case report.

Nicolle A Trudeau1, Jessica M Lawton1, Nirav D Patel1

  • 1Aurora BayCare Medical Center, Green Bay, USA.

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|March 19, 2021
PubMed
Summary
This summary is machine-generated.

Nail toxicities are a frequent side effect of pemigatinib, a treatment for cholangiocarcinoma. Close monitoring is essential to manage these side effects and potentially adjust treatment.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Pemigatinib is a key second-line treatment for cholangiocarcinoma.
  • Nail toxicities are a commonly reported side effect in patients receiving pemigatinib.
Keywords:
Pemigatinibcholangiocarcinomafibroblast growth factor receptor inhibitornail toxicitytyrosine kinase inhibitor

More Related Videos

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.4K
Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy
05:06

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy

Published on: February 28, 2025

573

Related Experiment Videos

Last Updated: Nov 12, 2025

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:31

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

143
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.4K
Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy
05:06

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy

Published on: February 28, 2025

573